Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Aon plc (NYSE: AON), a leading global professional services firm, today announced a strategic investment in eMed Population ...

Aon has invested in eMed Population Health, a provider of GLP-1 programs, to expand employer-sponsored access to GLP-1 ...

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform ...

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...